United States Sues Walgreens Over Violations of the Controlled Substances Act and False Claims Act Read more
Pfizer’s Subsidiary Biohaven Settles for Nearly $60M Over Speaker Programs: Complaint included Significant Open Payments Under Reporting Read more
QOL Medical and Their CEO Settle for $4.7 Million Over Alleged Kickback Scheme Involving Genetic Testing and Drug Claims Read more
Acadia Healthcare Reaches $19.85 Million Settlement to Resolve False Claims Act Allegations Read more
